Share Price:

APNASPENAspen Pharmacare Hldgs154480 (0.00%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Aspen champions local manufacturing at the 2026 Manufacturing Indaba

In July, our Group Senior Executive: Strategic Trade, Stavros Nicolaou, represented Aspen at the 2026 Manufacturing Indaba, one of Africa’s leading platforms for advancing industrial growth, localisation and manufacturing-led economic development. This year, there was a particular focus on establishing domestic and regional pharmaceutical value chains for export led growth into the African continent in line with the African Union’s ambition to produce 60% of Africa’s pharmaceutical requirements in Africa by 2040.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: